Project Grant R44AG058277

Award Date 9/15/17
Completion Date 7/31/24
Dollars Obligated $4.9M
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
California, USA
Similar Awards
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $864,674 to Lifebio Inc., a self-certified small disadvantaged business, to develop a tablet-based platform called "LifeBioTalk." The LifeBioTalk platform is designed to provide engaging audio-visual content narrated by a human-like avatar to people with Alzheimer's disease and related dementias (ADRD). The goal is to use this simulated conversational experience to reduce challenging...
This Project Grant award from the National Center for Complementary and Integrative Health (NCCIH), under the Research and Training in Complementary and Integrative Health program (CFDA 93.213), will support a 5-year, $151,672 research project to culturally tailor a mindfulness meditation mobile app to reduce psychological distress in African American adults. The key products/services to be delivered through this funding include: Focus groups with African American adults to inform development of...
The National Institute on Aging (NIA), under the Aging Research federal grant program (CFDA 93.866), awarded a $232,485 Project Grant (R21AG085254) to the University of Alabama at Birmingham (UAB). The grant funding will support the adaptation and feasibility testing of an AI-enabled web application based on Acceptance and Commitment Therapy (ACT) for family caregivers of people living with dementia. The key products and services to be delivered under this grant include: Adapting an existing...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $811,228 to B.A. Maze, Inc. to develop and test the At-Home Health Station (AHS), a technology platform designed to assist individuals with cognitive impairment and Alzheimer's disease-related dementias (CI/ADRD) in maintaining independence and health. The AHS is a modular, plug-and-play system that simplifies digital experiences for CI/ADRD users and enables caregivers to set customized...
This $349,333 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) supports the development and feasibility testing of a virtual reality (VR) platform called "VR-CARES" to provide social support and enrichment for in-home dementia caregivers. The key products and services to be delivered through this STTR Phase I study include: Co-developing the VR-CARES platform with input from dementia caregivers to ensure it aligns with their needs and experiences....
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $242,992 to the Regents of the University of California, San Francisco (UCSF) to co-develop and pilot test a digital symptom assessment tool (CARES) for caregivers of homebound older adults with serious illness, including those with cognitive impairment or Alzheimer's disease. The project aims to: 1) adapt an existing symptom assessment toolkit to address unique needs related to...
The National Institute on Aging (NIA) awarded Beaver Health, Inc. a $499,996 Project Grant under the Aging Research federal grant program (CFDA 93.866) to develop a prototype of the COMPASS conversational AI assistant. COMPASS is designed to provide real-time, personalized, and culturally responsive support for Alzheimer's disease and related dementia (ADRD) caregivers. The key products/services to be delivered through this 12-month project include: A prototype conversational AI platform that...
The National Center for Complementary and Integrative Health (NCCIH) awarded a $143,960 Project Grant under the Research and Training in Complementary and Integrative Health program (CFDA 93.213) to Autotune Me LLC, a minority-owned and woman-owned small business located in Brooklyn, NY. The project aims to develop a therapeutic, music-based mobile application called "Tune Den" to combat neuropsychiatric symptoms in people living with Alzheimer's disease and related dementias. The...
This Project Grant award from the National Center for Complementary and Integrative Health (NCCIH), under the Research and Training in Complementary and Integrative Health program (CFDA 93.213), provides $165,240 to the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University to develop and pilot test a daily, digitally-delivered mindfulness-based intervention called MINDSET. The goal is to reduce depressive symptoms in post-treatment cancer patients, a population at high...
This Project Grant awarded by the National Institute on Aging (CFDA 93.866 Aging Research) to the Trustees of Indiana University aims to culturally adapt a mobile caregiver intervention called Brain CareNotes for Hispanic dementia caregivers. The $356,974 award will fund a mixed-methods study to assess the needs of Hispanic Alzheimer's and related dementia (ADRD) caregivers and develop modifications to integrate cultural factors that impact ADRD symptomology and caregiver burden. Guided by an...

MINDFULNESS-BASED COGNITIVE COPING MOBILE APP INTERVENTION FOR CAREGIVERS OF INDIVIDUALS WITH ALZHEIMER'S DISEASE - PROJECT SUMMARY ALZHEIMER'S DISEASE (AD) IS A DEVASTATING ILLNESS FOR PATIENTS, FAMILIES, AND SOCIETY. MOST OF THE CARE OF AD PATIENTS RESTS ON SHOULDERS OF INFORMAL CAREGIVERS, LARGELY UNTRAINED TO UNDERTAKE THE CAREGIVING ROLE, BEARING A HIGH LEVEL OF DISTRESS, AND SUFFERING DETERIORATION IN PHYSICAL HEALTH AND PSYCHOLOGICAL WELL-BEING. THERE ARE OVER 16 MILLION AMERICANS PROVIDING CARE TO AD PATIENTS, EXPERIENCING HIGH RATES OF DEPRESSIVE SYMPTOMS (30%), STRESS (59%), ASSOCIATED RISKS FOR CARDIOVASCULAR DISEASES, AND MANY OTHER ADVERSE HEALTH EFFECTS. FOR EXAMPLE, IN SEPARATE STUDIES, HOSPITALIZATION AND EMERGENCY DEPARTMENT VISITS WERE MORE LIKELY FOR DEMENTIA CAREGIVERS THAN ANY OTHER TYPES OF CAREGIVERS. THE SEVERITY OF AD CAREGIVING IS INFLUENCED BY SEVERAL FACTORS, SUCH AS INTENSITY OF DEMENTIA SYMPTOMS IN AD PATIENTS, HOW CHALLENGING DISTRESSFUL SITUATIONS ARE PERCEIVED BY CAREGIVERS, AND AVAILABLE RESOURCES. ALTHOUGH INFORMATION AND PROGRAMS ABOUT ALZHEIMER'S DISEASE ARE AVAILABLE TO THE PUBLIC, AN ESSENTIAL MISSING TOOL IS HOW TO DEAL WITH DEPRESSIVE SYMPTOMS IN AN EFFECTIVE MANNER, AS THEY ARE VERY COMMON AND DEMANDING. THEREFORE, IN THIS PHASE II PROJECT, WE PROPOSE TO COMPLETE THE NEW MINDFULNESS-BASED COGNITIVE COPING (MCC) INTERVENTION, AND ENABLE EASY ACCESS WITH OUR MOBILE APP, CALLED CARING MIND APP (CMA), PROVIDING AN EFFECTIVE COST-EFFECTIVE INTERVENTION FOR CAREGIVERS TO REDUCE THEIR STRESS AND DEPRESSIVE SYMPTOMS. THE MCC INTERVENTION IS BUILT UPON THE MINDFULNESS-BASED COGNITIVE THERAPY (MBCT), WHICH HAS BEEN EFFECTIVE TO TREAT INDIVIDUALS WITH MAJOR DEPRESSIVE DISORDER, WITH THE INTEGRATION OF CAREGIVING COPING STRATEGIES FROM OUR PAST STUDIES TO HELP CAREGIVERS TO OVERCOME STRESSFUL SITUATIONS IN THEIR CAREGIVER ROLE. INNOVATION: (1) INTEGRATION OF MBCT WITH CAREGIVING COPING IN A MOBILE APP; (2) ANONYMOUS SHARING OF REAL RESPONSES AND TECHNIQUES USED BY CAREGIVERS; AND (3) AUTOMATED CONTENT UPDATE THROUGH AN ADVANCED "CROWDSOURCING" OF CAREGIVING KNOWLEDGE (AFTER "CURATION" BY PROJECT PERSONNEL) TO PROMOTE BEST PRACTICES. PHASE I DEMONSTRATED THE FEASIBILITY, MET ALL MILESTONES, AND PROVIDED EVIDENCE TO SUPPORT THE CONCEPT (MCC IN APP FORMAT). AD CAREGIVERS WERE ABLE TO USE THE CARING MIND MOBILE APP AND ACCEPTED IT VERY WELL. IN FACT, BESIDES DEMONSTRATING USABILITY, ACCEPTANCE AND PERCEIVED BENEFITS, PHASE I STUDY SHOWED SIGNIFICANT POSITIVE OUTCOMES FOR CAREGIVERS ON REDUCING THEIR DEPRESSIVE SYMPTOMS AND PSYCHOLOGICAL STRESS. IN PHASE II, WE WILL FINALIZE THE MCC CURRICULUM, DEVELOP THE COMPLETE APP, AND EVALUATE ITS EFFECTIVENESS IN A RANDOMIZED CLINICAL TRIAL; RESULTING IN A NOVEL INTERVENTION THAT INTEGRATES MCC CONTENT, AGGREGATION OF COMMUNITY SHARED EXPERIENCE, EFFECTIVE TRAINING TO REDUCE DEPRESSIVE SYMPTOMS AND PSYCHOLOGICAL STRESS, AND A MOBILE APP TO BE DEPLOYED TO MILLIONS OF FAMILIES STRUGGLING WITH ALZHEIMER'S DISEASE. COMMERCIAL OPPORTUNITY: MCC PROGRAM WILL BE AVAILABLE TO AD CAREGIVERS (16+ MILLION PEOPLE IN US) AS A MOBILE APP SUBSCRIPTION. THIS MODEL HAS BEEN VERY SUCCESSFUL WITH OUR CURRENT MOBILE APPS IN APP STORES.

Posted 8/11/21, 12:00 AM